One-carbon therapeutics wins ELAVITY Pitch Event

by admin
juni 28, 2022

Our team is happy and proud to have been voted as the winner for pitching our MTHFD1/2 inhibitor program.

https://www.linkedin.com/feed/update/urn:li:activity:6948268990171365376

Rekommenderade artiklar

Dr Eva Ehrnrooth, MD PhD to join One-carbon Therapeutics AB management team as interim CMO

Dr Eva Ehrnrooth (MD PhD) brings + 20 years of

One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe

One-carbon therapeutics AB is discussing the ODIN trial with several

Our Founder Prof Thomas Helleday wins the Anders Jahre’s price in Medicine

Read the article here.

Menu bar